A luteinizing hormone-releasing hormone (LHRH) analog used in the palliative hormonal treatment of advanced prostate cancer and sometimes in the adjuvant and neoadjuvant hormonal treatment of earlier stages of prostate cancer. A U.S. brand name is Zoladex. See hormone therapy.